PHIA Koninklijke Philips N.V.

Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience

Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience

March 3, 2021

  • 2000th customer installation of Philips Ambient Experience at bdz Bilddiagnostisches Zentrum Münster in Germany
  • 91% of surveyed users are likely or extremely likely to recommend Philips Ambient Experience to other hospitals

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 2000th installation of its revolutionary patient-centric , together with the results of a comprehensive customer survey that reveals 91% of users are likely, or extremely likely, to recommend Philips Ambient Experience to other hospitals. The survey also further confirms the solution’s ability to help hospitals deliver on the quadruple aim of enhanced patient and staff experiences, better outcomes, and lower cost of care. Philips’ 2000th Ambient Experience install started at the bdz Bilddiagnostisches Zentrum Münster in Germany, as an integral part of the diagnostic center's newly equipped radiology suite.

Philips Ambient Experience solution is a unique combination of optimized design, site planning, proprietary software, lighting, sound, video projection and multimedia content that applies human-focused innovation and design thinking to offer hospital patients and staff an engaging and pleasant experience. It can be applied both in radiology exam/treatment rooms and peripheral areas such as reception areas and waiting rooms.

The majority of survey respondents indicate that Ambient Experience decreases patient tension (76%) and fear (71%), induces patient calmness (66%), and improves cooperation during exams (63%). Ambient Experience is found to have the highest added value for patients with claustrophobia or anxiety, pediatric patients, and patients undergoing longer studies like MRI exams. By helping to improve the patient experience and reducing anxiety, Ambient Experience can help facilitate first-time-right scans and diagnoses to help drive better health outcomes, improved hospital efficiency, and higher patient and staff satisfaction.

“Health systems are looking for ways to increasing patient satisfaction while improving patient throughput and compliance in diagnostic imaging,” said Werner Satter, General Manager Healthcare Experience Solutions at Philips. “Our customers confirm that Ambient Experience helps them improve the patient experience, reducing the patient’s anxiety and thereby increasing first-time-right imaging.”

Customer survey results across Europe and the U.S.

Analysis of the information provided by 59 respondents across Europe and the U.S. to a customer survey, conducted on behalf of Philips by The MarkeTech Group, indicate improved patient experience (endorsed by 83% of respondents) to be their most valuable attribute of using Ambient Experience in radiology exam rooms. The majority of customers surveyed (83%) indicated that Ambient Experience is at least impactful, and up to extremely impactful, in alleviating patient anxiety.

Based on their current use of the solution, 91% were likely or extremely likely, to recommend their current Ambient Experience offering to another hospital, and 87% were likely, or extremely likely, to include Ambient Experience as part of a new purchase. 75% of respondents in the US and 59% in Europe believe that Ambient Experience encourages patients to choose their facility.

The ability of Ambient Experience to help hospitals deliver on the quadruple aim is also supported by multiple studies across hospital sites in Germany, Denmark and the UK. More information is available in the .

Philips is showcasing its during the European Congress of Radiology (ECR) virtual event (March 3-7, 2021). For more information on Philips’ new portfolio of diagnostic and interventional solutions and AI-enabled applications to enhance radiology workflows at ECR 2021, visit the , and follow for updates throughout the event.

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail :

Twitter:

Mark Groves

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



Attachments



EN
03/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips announces collaboration with Epic to enhance ambulatory cardia...

Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring July 24, 2025 Philips will now offer the largest cardiac care portfolio through Epic’s Aura platform CAMBRIDGE, Mass. – (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with to integrate Philips’ suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty diagnostics suite of the leading electronic health record (EHR) company. This collaboration will offer the broadest cardiac care portfolio of any single service provider integrating...

 PRESS RELEASE

Philips advances minimally invasive therapy procedures in prostate can...

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with the FDA 510(k) clearance of the latest . The system includes a new advanced annotation [1] workflow that supports clinicians during focal thera...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ASM International: 2Q25 Results; Positive tone, weak orders. CM.com: 1H25 results; disappointing performance, guidance downgrade. Gimv: Gimv fuels Hemink's sustainable expansion. KPN: Solid 2Q25, guidance raised largely on €25m IPR claim benefit. Philips: 2Q25 Preview; improvement needed. Randstad: 2Q25 in line; outlook touch below; FX spoils the party but operational leverage story is unfolding. Sofina: Newsletter #16. Universal Music Group: EU opens in-depth investigation into Downtown ...

 PRESS RELEASE

Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis

Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to multiple vendor offerings all in one central location to help clinicians manage and implement AI-powered diagnostic tools more easily. , an AI-driven health technology company committed to tran...

 PRESS RELEASE

Philips Foundation 2024 Annual Report: expanding access to quality hea...

Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people In 2024, Philips Foundation initiated 22 new projects and 5 new impact investments expanding its impact and reach in innovative healthcare delivery to India and South AmericaCelebrating a decade of impact with strong progress towards the Foundation’s 2030 goal to improve access to healthcare for 100 million people in underserved communities a yearThe combined impact of longstanding strategic collaborations and new innovative partnerships with healthcare ventures affirm the Foundation’s appr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch